Trials / Recruiting
RecruitingNCT05874141
Comorbidities in Type 2 Diabetes Mellitus
Comorbidities in Type 2 Diabetes Mellitus: An Observational Study in Kharga City, New Valley Governate, Egypt
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 288 (estimated)
- Sponsor
- New Valley University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today
Detailed description
All-cause mortality rates have declined substantially in several high-income countries, including England. A diversification in non-fatal conditions in people with DM has also been reported. This is attributable to broader, non-vascular conditions. Due to increasing longevity among people with type 2 DM with increasing and diversifying multimorbidity in them, the health needs of people with Type 2 DM are therefore likely to be broad, and complex. Finding multimorbidity (two or more chronic conditions) is common in people with Type 2 DM and increasing, but the comorbidity profiles of people with T2DM vary substantially. Many studies have primarily focused on identifying multimorbidity patterns in the general population. The understanding of multimorbidity patterns and composition of specific comorbidities in people with DM, and how this varies across patient groups and during the course of the disease, is limited. Further knowledge of this could provide insight into providing more holistic and more personal approaches to clinical guideline development, care pathways, and secondary prevention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HBA1C | blood sample on EDTA |
| DIAGNOSTIC_TEST | Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides | serum sample |
| DIAGNOSTIC_TEST | Urine analysis and urinary albumin-to-creatinine ratio | Morning urine sample |
| DIAGNOSTIC_TEST | Serum creatinine and estimated glomerular filtration rate | serum sample |
| DIAGNOSTIC_TEST | Complete blood count | blood sample on EDTA |
| DIAGNOSTIC_TEST | Thyroid-stimulating hormone | serum sample |
| DIAGNOSTIC_TEST | Serum iron, TIBC, Transferrin saturation and serum ferritin if needed | serum sample |
| PROCEDURE | Electrocardiography (ECG) | by electrocardiogram |
| PROCEDURE | Transthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound | imaging |
| PROCEDURE | Arterial duplex ultrasound of both lower limbs | imaging |
| DIAGNOSTIC_TEST | Random blood glucose | serum sample |
| DIAGNOSTIC_TEST | AST, ALT, albumin | serum sample |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2025-12-30
- Completion
- 2026-08-30
- First posted
- 2023-05-24
- Last updated
- 2025-08-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05874141. Inclusion in this directory is not an endorsement.